Nachrichten zur Nevro Corp. Aktie

Nevro Corp. (NVRO) Q4 2023 Earnings Call Transcript

…

Nevro Corp. (NVRO) Q3 2023 Earnings Call Transcript

…

Expert Ratings for Nevro

Latest Ratings for NVRO DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform View…

Why Shares of Nevro Are Down Wednesday

The medical device maker saw increased revenue, but earnings lagged estimates....…

Nevro (NVRO) Q2 Earnings Lag Estimates, FY23 View Cut

Nevros (NVRO) worldwide revenues improve on a year-over-year basis in the second quarter owing to robust domestic and international performances....…

TRxADE, Armata top healthcare gainers; Adamis, Nevro among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q NEVRO CORP For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance

Company Takes Proactive Steps to Improve Commercial Execution and Maximize Growth Opportunities REDWOOD CITY, Calif., Aug. 1, 2023 /PRNewswire/ --…

Form 8-K NEVRO CORP For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro to Report Second Quarter 2023 Financial Results

Company to Host Conference Call on Tuesday, August 1, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY,…

3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio

Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge....…

Nevro hits 52-week low after Q2 guidance cut

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K NEVRO CORP For: Jun 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro Names New Chief Commercial Officer

Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus Company Updates Second Quarter 2023 Revenue Guidance REDWOOD…

RBC Capital starts Nevro at outperform, views stock as undervalued

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K NEVRO CORP For: May 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro gains as Oppenheimer upgrades citing balanced risk reward

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro (NVRO) Q1 Earnings and Revenues Surpass Estimates

Nevros (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance....…

Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 7.55% and 1.06%, respectively, for the quarter ended March 2023. Do the…

Form 10-Q NEVRO CORP For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance

REDWOOD CITY, Calif., April 26, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering…

Nevro Announces Participation in Upcoming Investor Conferences

REDWOOD CITY, Calif., April 24, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering…

Why Nevro Stock Is Tanking Today

The moody market is punishing this medical device stock yet again today....…

Augmedix, CNS top healthcare gainers; Windtree, Nevro among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro names Hologic executive as CEO, posts prelim. Q1 revenue above consensus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro Taps Kevin Thornal as President, CEO

Nevro Taps Kevin Thornal as President, CEO...…

Form 8-K NEVRO CORP For: Apr 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro Names Kevin Thornal as New Chief Executive Officer and President

D. Keith Grossman to be Appointed as Executive Chairman Company Announces Preliminary, Unaudited Worldwide Revenue for First Quarter of 2023…

5 Analysts Have This to Say About Nevro

Latest Ratings for NVRO DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform View…

Nevro started at neutral with $40 stock price target at Mizuho

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro to Report First Quarter 2023 Financial Results

Company to Host Conference Call on Wednesday, April 26, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY,…

Nevro to Participate in Wells Fargo 2023 Medtech Innovation Spotlight Call Series

Friday, March 24, 2023 at 2:00 pm Eastern Time REDWOOD CITY, Calif., Feb. 23, 2023 /PRNewswire/ -- Nevro Corp. (NYSE:…

Nevro falls to 52-week low; down ~49% over last year

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K NEVRO CORP For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nevro (NVRO) Q4 Earnings Lag Estimates, Revenues Beat

Nevros (NVRO) worldwide revenues improve on a year-over-year basis in Q4, partly owing to robust domestic performance....…

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of -10.20% and 0.52%, respectively, for the quarter ended December 2022. Do the…

Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides First Quarter and Complete Full-Year 2023 Guidance

REDWOOD CITY, Calif., Feb. 16, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering…

Strength Seen in Nevro (NVRO): Can Its 5.1% Jump Turn into More Strength?

Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year

Leading Indicator Aimed at Increasing Transparency Surrounding Gender-Related Practices and Policies REDWOOD CITY, Calif., Jan. 31, 2023 /PRNewswire/ -- Nevro…

Where Nevro Stands With Analysts

Latest Ratings for NVRO DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform View…

Nevro to Highlight New Clinical Evidence at the 2023 North American Neuromodulation Society (NANS) 26th Annual Meeting

REDWOOD CITY, Calif., Jan. 12, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing…

Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance

Company Announces 2023 Retirement Plans of D. Keith Grossman from Positions of CEO and President; Will Remain as Chairman of…

dpa-AFX ProFeed